International Assets Investment Management’s GSK GSK Stock Holding History

International Assets Investment Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5,540	Closed	-$226K	–	1232
2024 Q3	$226K	Buy	5,540 +5	+0.1%	+$205	0.02%	562
2024 Q2	$213K	Buy	5,535 +327	+6%	+$13.8K	0.02%	682
2024 Q1	$221K	Buy	+5,208	New	+$215K	0.02%	643
2023 Q1	–	Sell	-12,199	Closed	-$429K	–	1238
2022 Q4	$429K	Buy	+12,199	New	+$406K	0.04%	379
2021 Q4	–	Sell	-6,975	Closed	-$333K	–	544
2021 Q3	$333K	Sell	6,975 -1,013	-13%	-$50.9K	0.06%	317
2021 Q2	$398K	Buy	7,988 +4,037	+102%	+$194K	0.07%	273
2021 Q1	$182K	Hold	3,951	–	–	0.02%	536
2020 Q4	$182K	Buy	+3,951	New	+$181K	0.03%	401
2020 Q2	–	Sell	-4,692	Closed	-$222K	–	419
2020 Q1	$222K	Buy	+4,692	New	+$250K	0.07%	252

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

International Assets Investment Management's GSK Position: Q4 2024 in Review

International Assets Investment Management sold out of GSK (GSK) in Q4 2024, closing a stake of 5,540 shares — an estimated $226K sold.

International Assets Investment Management first reported a position in GSK in Q1 2020 and held it in 9 quarters. The position peaked at $429K in Q4 2022. 850 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

International Assets Investment Management reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
International Assets Investment Management sold 5,540 GSK shares in Q4 2024, an estimated $226K.
International Assets Investment Management first reported a position in GSK in Q1 2020 and held it in 9 quarters.
International Assets Investment Management's GSK position peaked at $429K in Q4 2022.
850 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on International Assets Investment Management's 13F filing for Q4 2024, filed 8 Jan 2025.